HIGHLIGHTS
- who: Report and collaborators from the Milwaukee, USA Department of Medicine, Medical College of Wisconsin, Milwaukee, USA have published the Article: Review began 06/10/2022 Review ended 06/22/2022 Published 06/23/2022 u00a9 Copyright, in the Journal: (JOURNAL) of June/23,/2022
- what: DNMN is considered a manifestation of antibody-mediated rejection and requires treatment with immunosuppressive therapy.
SUMMARY
Membranous nephropathy (MN) is known to be the most common cause of nephrotic syndrome. PMN can be subdivided into de novo (DNMN) and recurrent membranous nephropathy (RMN), both of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.